Pathogenic Study of Adult Immune Enteropathies

Recruiting Observational Study
Celiac Disease Autoimmune Enteropathy Inflammatory Bowel Diseases
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
200 (estimated)
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France · Government
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The study focuses the mechanisms underlying the loss of intestinal homeostasis in celiac disease, refractory celiac disease and other immune diseases such as monogenic enteropathy, inflammatory bowel diseases or drug induced intestinal diseases. Mechanisms of transformation of lymphocytes leading to onset of lymphomatous complications of immune enteropathies will be investigated. Mechanisms of los…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * 18 years or over * affiliated to social insurance * signed informed consent Exclusion Criteria: * pregnancy * under guardianship * not able to sign informed consent
Contacts

Georgia MALAMUT, MD, PhD

33 1 58 41 41 76

georgia.malamut@aphp.fr

CONTACT

Anaïs LEVESCOT, MD, PhD

33 1 42 75 42 77

anais.levescot@inserm.fr

CONTACT